n/a: n/a

aTyr Pharma, Inc. (LIFE: NASDAQ)

$3.55 n/a | n/a%
02/17/17 - 04:00 PM ET
Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013
Cash and Equivalents 53.02M 13.90M 36.46M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 97.95M 16.51M 37.02M
Property, Plant & Equipment, Gross 1.79M 4.89M 4.64M
Accumulated Depreciation & Depletion 0.00 2.96M 2.13M
Property, Plant & Equipment, Net 1.79M 1.93M 2.50M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 29.93M 2.21M 260.00K
Total Non-Current Assets 31.73M 4.13M 2.77M
Liabilities & Shareholder Equity
Total Assets 129.68M 20.64M 39.79M
Accounts Payable 3.87M 1.43M 1.05M
Short Term Debt 3.37M 3.13M 728.00K
Other Current Liabilities 0.00 319.00K 207.00K
Total Current Liabilities 12.15M 10.11M 5.21M
Long Term Debt 1.78M 5.14M 6.16M
Deferred Income Taxes 130.00K 445.00K 741.00K
Other Non-Current Liabilities 571.00K 335.00K 597.00K
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 2.48M 101.54M 103.08M
Total Liabilities 14.62M 111.65M 108.28M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 115.05M -91.01M -68.50M
Common Par 24.00K 1.00K 1.00K
Additional Paid In Capital 273.32M 19.21M 17.37M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -158.12M -110.15M -85.80M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -171.00K -69.00K -69.00K
Total Capitalization 116.83M -85.87M -62.34M
Total Equity 115.05M -91.01M -68.50M
Total Liabilities & Stock Equity 129.68M 20.64M 39.79M
Total Common Shares Outstanding 23.67M 22.55M 22.55M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 15.84M 0.00 0.00
Diluted Weighted Shares Outstanding 15.84M 0.00 0.00
Number of Employees 55 NA NA
Number of Part-Time Employees 0 NA NA

Portfolios with LIFE

Latest LIFE Headlines from TheStreet

More Financial News for LIFE

Press Releases for LIFE

See All Press Releases

Partner Headlines for LIFE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter